HomeInsightsPE

Ajanta Pharma Ltd PE Ratio

Ajanta Pharma Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

0.8 K

stocks traded

Last Updated time: 11 Oct 13:25 PM

Image

Ajanta Pharma Ltd

NSE: AJANTPHARM

PE

48.9

Last updated: 11 Oct 13:25 PM

Key Highlights

  • The P/E Ratio of Ajanta Pharma Ltd is 48.9 as of 11 Oct 13:25 PM.
  • The P/E Ratio of Ajanta Pharma Ltd changed from 23.4 on March 2019 to 34.7 on March 2024 . This represents a CAGR of 6.79% over 6 years. .
  • The Latest Trading Price of Ajanta Pharma Ltd is ₹ 3355 as of 11 Oct 13:17.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Ajanta Pharma Ltd

No data available

Company Fundamentals for Ajanta Pharma Ltd

No data available

Image

Ajanta Pharma Ltd

NSE: AJANTPHARM

PRICE

3355.5

15.05 (0.45%)

stock direction

Last updated: 11 Oct 13:17

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Ajanta Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
10 Oct 20243340.45
09 Oct 20243371
08 Oct 20243391.95
07 Oct 20243300.2
04 Oct 20243327.25
03 Oct 20243347.85
01 Oct 20243257.1
30 Sep 20243198.95
27 Sep 20243338.3
26 Sep 20243183.3

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ajanta Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ajanta Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Ajanta Pharma Ltd4841,726
Sun Pharmaceuticals Industries Ltd424,52,850
Divis Laboratories Ltd941,57,702
Cipla Ltd291,30,709
Torrent Pharmaceuticals Ltd691,16,560
Dr Reddys Laboratories Ltd191,09,846

Key Valuation Metric of Ajanta Pharma Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Ajanta Pharma Ltd

No data available

* All values are in %

About Ajanta Pharma Ltd

  • Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
  • The Company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets.
  • It produces a comprehensive range of specialty products targeting different therapeutic segments.
  • It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
  • The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

Ajanta Pharma Ltd News Hub

News

Ajanta Pharma hits record high after Q1 PAT rises 19% YoY to Rs 246 cr

Profit before tax increased 19.73% YoY to Rs 322.12 crore in Q1 FY25. EBITDA stood at Rs 3...

Read more

30 Jul 202415:46

News

Ajanta Pharma to conduct board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 July 2024...

Read more

18 Jul 202410:38

News

Ajanta Pharma AGM scheduled

Ajanta Pharma announced that the 45th Annual General Meeting (AGM) of the company will be ...

Read more

15 Jun 202410:25

News

Ajanta Pharma spurts as Q4 PAT climbs 66% YoY, board OKs Rs 285-cr share buyback

Profit before tax soared 82.86% to Rs 278.04 crore in Q4 FY24 from Rs 152.05 crore reporte...

Read more

03 May 202410:22

News

Volumes jump at Ajanta Pharma Ltd counter

Coforge Ltd, Cummins India Ltd, Torrent Pharmaceuticals Ltd, Bajaj Finserv Ltd are among t...

Read more

03 May 202411:00

News

Volumes spurt at Ajanta Pharma Ltd counter

Coforge Ltd, Piramal Pharma Ltd, Kansai Nerolac Paints Ltd, Elgi Equipments Ltd are among ...

Read more

03 May 202414:30

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Ajanta Pharma Ltd

What is the current PE Ratio of Ajanta Pharma Ltd?

The Current PE Ratio of Ajanta Pharma Ltd is 48.87 as on 11 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Oct 2024.

What was the PE Ratio of Ajanta Pharma Ltd last year?

The PE Ratio of Ajanta Pharma Ltd was 25.98 last year, now the PE ratio is 48.87, showing a year-on-year growth of 88.1%.

What does the PE Ratio of Ajanta Pharma Ltd indicate about its stock?

The PE Ratio of Ajanta Pharma Ltd is 48.87. This ratio indicates that investors are willing to pay 48.87 times the earnings per share for each share of Ajanta Pharma Ltd.

What is the PE Ratio Growth of Ajanta Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Ajanta Pharma Ltd grew by 88.1% whereas, the EPS ratio grew by 21.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*